Hirata A, Yoshida H, Oyama Y, Akaike N
Cell Mol Neurobiol. 1986 Sep;6(3):255-62. doi: 10.1007/BF00711112.
Changes in the population of adrenergic alpha- and beta-receptors were examined in rat soleus muscles during hypokalemia by their direct determination using radiolabeled ligands. Only beta-adrenoceptors were detected in the normal rat muscles. Hypokalemia led to a pronounced decrease in beta-adrenoceptors, the number of [3H]DHA binding sites, by 50%, as compared with that in the normal rats. There was a genesis of alpha 1-adrenoceptors in hypokalemic rat muscles, since the competitive potency of adrenergic drugs against [3H]prazosin binding was in the order prazosin much greater than phentolamine greater than (+/-)-noradrenaline greater than yohimbine much greater than (+/-)-isoproterenol. The reduction of [3H]DHA binding sites was accompanied by an increase of an approximately equal amount in high-affinity [3H]prazosin binding sites. The Kd determined by kinetic analysis of [3H]prazosin binding was calculated from the ratio K-1/K1 that gave a value of 3.05 nM, which generally agreed with the 1.83 nM determined by saturation experiments (Scatchard plot). This phenomenon of a reduction in the beta-adrenoceptors and the occurrence of alpha 1-adrenoceptors in muscles during hypokalemia is discussed. alpha- and beta-adrenoceptors on soleus muscle membrane may play important but opposite roles in modulating potassium release from the muscle cells.
利用放射性标记配体直接测定法,研究了低钾血症大鼠比目鱼肌中肾上腺素能α和β受体数量的变化。正常大鼠肌肉中仅检测到β肾上腺素能受体。与正常大鼠相比,低钾血症导致β肾上腺素能受体数量显著减少,即[3H]DHA结合位点数量减少50%。低钾血症大鼠肌肉中出现了α1肾上腺素能受体,因为肾上腺素能药物对[3H]哌唑嗪结合的竞争效力顺序为:哌唑嗪>酚妥拉明>(±)-去甲肾上腺素>育亨宾>(±)-异丙肾上腺素。[3H]DHA结合位点的减少伴随着高亲和力[3H]哌唑嗪结合位点等量增加。通过对[3H]哌唑嗪结合的动力学分析确定的Kd值,由K-1/K1比值计算得出,其值为3.05 nM,这与饱和实验(Scatchard图)确定的1.83 nM基本一致。本文讨论了低钾血症期间肌肉中β肾上腺素能受体减少和α1肾上腺素能受体出现的现象。比目鱼肌膜上的α和β肾上腺素能受体在调节肌肉细胞钾释放方面可能发挥重要但相反的作用。